Sonomed Escalon™ Announces Integration of AXIS™ Image Management with MaximEyes EHR

    Sonomed Escalon™ Announces Integration of AXIS™ Image Management with
                                MaximEyes EHR

PR Newswire

WAYNE, Pa., June 24, 2013

WAYNE, Pa., June 24, 2013 /PRNewswire/ --Escalon® Medical Corp. (Nasdaq:
ESMC) today announced its Sonomed Escalon™ group has completed deep
integration of its AXIS™ Image Management platform with MaximEyes EHR
ophthalmic electronic health records system provided by First Insight®
Corporation. The integration enables users to directly access all patient
diagnostic images from directly within MaximEyes EHR.

"While AXIS can interface with any EHR system, the deep integration with
MaximEyes provides a greater convenience and saves users time," said Matthew
Carnevale, Sonomed Escalon's Chief Technology Officer. "MaximEyes EHR is a
leading EHR provider for ophthalmology and this integration further enhances
the value proposition of a combined solution."

"Partnering with Sonomed Escalon continues our commitment to expand MaximEyes
EHR functionalities with certified partner integrations and to help practices
simplify managing their patient data," said Nitin Rai, President and CEO of
First Insight® Corporation. "This built-in integration allows MaximEyes EHR
users to quickly connect to the Sonomed Escalon AXIS image management system,
and display exam records and diagnostic images for a specific patient. In
addition, MaximEyes users can host this integration locally or in a cloud
environment."

About Escalon Medical: Founded in 1987, Escalon Medical Corp.
(www.escalonmed.com) develops markets and distributes ophthalmic diagnostic
and surgical products. The Company seeks to further develop and diversify its
product offering through internal development programs, strategic
partnerships, and acquisition of technology so as to best leverage the
Company's distribution capabilities, although such development, partnerships
or acquisitions may or may not occur. The Company has headquarters in Wayne,
Pennsylvania and operations in Lake Success, New York, New Berlin, Wisconsin
and Stoneham, Massachusetts.

About First Insight Corporation: First Insight was founded in 1994 by Nitin
Rai, president and CEO, to revolutionize and lead the eye care industry with
the most complete and customizable certified electronic health records and
practice management software. The company's focus has been to help doctors
achieve a paperless practice through MaximEyes, its flagship "eye care only"
Cloud-based EHR and practice management software. MaximEyes helps thousands of
eye care professionals increase revenue, reduce billing errors, improve
patient retention, enhance office efficiency, and relieve the stress of
regulatory requirements. The company provides award winning training and
development to make implementation simple. First Insight is headquartered in
Hillsboro, OR. To learn more, visit www.first-insight.com.

Note: This press release contains statements that are considered
forward-looking under the Private Securities Litigation Reform Act of 1995,
including statements about the Company's future prospects. These statements
are based on the Company's current expectations and are subject to a number of
uncertainties and risks, and actual results may differ materially. The
uncertainties and risks include whether the Company is able to:

  oimplement its growth and marketing strategies, improve upon the operations
    of the Company business units, including the ability to make acquisitions
    and the integration of any acquisitions it may undertake, if any, of which
    there can be no assurance,
  ogrow our remaining ophthalmic business unit,
  oimplement cost reductions,
  ogenerate cash,
  oidentify, finance and enter into business relationships and acquisitions.

Other factors include uncertainties and risks related to:

  onew product development, commercialization, manufacturing and market
    acceptance of new products,
  omarketing acceptance of existing products in new markets,
  oresearch and development activities, including failure to demonstrate
    clinical efficacy,
  odelays by regulatory authorities, scientific and technical advances by the
    Company or third parties,
  ointroduction of competitive products,
  oability to reduce staffing and other costs and retain benefit of prior
    reductions,
  othird party reimbursement and physician training, and
  ogeneral economic conditions.

Further information about these and other relevant risks and uncertainties may
be found in the Company's report on Form 10- K for year ended June 30, 2012,
and its other filings with the Securities and Exchange Commission, all of
which are available from the Securities and Exchange Commission as well as
other sources.

SOURCE Escalon Medical Corp.

Website: http://www.escalonmed.com
Contact: Richard J. DePiano, Chairman and CEO, +1-610-688-6830